Scotland · NHS Scotland MSAN
Mirtazapine 15mg and 45mg orodispersible tablets
MSAN(2020)57 · Level 2 · issued 26 Jun 2020
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Mirtazapine 15mg and 45mg orodispersible tablets are out of stock until late July 2020. | Out of stock | late July 2020 |
| 3. Mirtazapine 30mg orodispersible tablets remain available but cannot support any increase in | Available — cannot support uplift | — |
| 4. Mirtazapine 15mg, 30mg and 45mg tablets remain available. | Available | — |
| 5. Mirtazapine 15mg/ml oral suspension remains available but cannot support any increase in | Available — cannot support uplift | — |
| switching to an alternative antidepressant which is available in a suitable formulation using | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.